LifeMD (LFMD) Investor presentation summary

Platform scale and care delivery

• Over 453 million platform interactions and 365,000+ active patients, with 1.95 million unique monthly website visitors.

• End-to-end care platform supports both synchronous and asynchronous visits across primary and specialty care.

• Integrated medical and pharmacy benefits expand patient access, reduce costs, and improve adherence.

• Nationwide affiliated medical group delivers consistent, high-quality care across 50 states.

• Platform proven to deliver complex virtual care at scale for over 200 conditions.

AI and technology infrastructure

• AI tools augment clinicians, increasing throughput and consistency in diagnosis and treatment.

• AI clinical decision support tool launching in Q2 2026, connecting to patient records for efficient, auditable care.

• AI agents support pre-consult data collection, consult transcription, scheduling, and revenue cycle management.

• Proprietary technology stack and large, structured patient database create a durable AI advantage.

• Internal AI leadership and third-party partnerships drive advanced AI deployment.

Pharmacy and benefits infrastructure

• Fully licensed 50-state pharmacy with direct integration to the virtual care platform.

• Strategic collaborations with Eli Lilly, Novo Nordisk, and HRT Club for GLP-1 and hormonal health.

• AI-enabled 503-A compounding licensure across 35 states, expanding to all 50 by year-end.

• Nationwide benefits infrastructure covers 112M lives today, expanding to 230M+ by Q2 2026.

• Real-time benefit verification, prior authorization, and claims management enhance access and affordability.